To visualize if these mutations altered FAK localization at FAs, we analyzed paxillin localization by immunofluorescence, a marker of FAs, in FAK-depleted A375 melanoma cells expressing FAK-WT-GFP or FAK-I936/I998-GFP. The gene discussed is PXN; the disease is melanoma.